Hamostaseologie

Hamostaseologie

HAMOSTASEOLOGIE
影响因子:2.4
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:GERMANY
出版社:Schattauer GmbH
发刊时间:1981
发刊频率:Bimonthly
收录数据库:SCIE/Scopus收录
ISSN:0720-9355

期刊介绍

Hämostaseologie is an interdisciplinary specialist journal on the complex topics of haemorrhages and thromboembolism and is aimed not only at haematologists, but also at a wide range of specialists from clinic and practice. The readership consequently includes both specialists for internal medicine as well as for surgical diseases.
Hämostaseologie是一本关于出血和血栓栓塞复杂主题的跨学科专业期刊,不仅面向血液学家,也面向来自临床和实践的广泛专家。因此,读者群包括内科和外科疾病的专家。
年发文量 55
国人发稿量 8.46
国人发文占比 0.15%
自引率 -
平均录取率0
平均审稿周期 较慢,6-12周
版面费 -
偏重研究方向 HEMATOLOGY-
期刊官网 http://haemo.schattauer.de/en/home.html
投稿链接 http://mc.manuscriptcentral.com/hamo

期刊高被引文献

Role of Endothelial Cells in Acute and Chronic Thrombosis.
来源期刊:HamostaseologieDOI:10.1055/s-0038-1675614
Lemierre Syndrome: Clinical Update and Protocol for a Systematic Review and Individual Patient Data Meta-analysis.
来源期刊:HamostaseologieDOI:10.1055/s-0038-1654720
Management of Helicobacter pylori in Patients with Immune Thrombocytopenia.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1683974
Pathophysiology of Autoimmune Thrombocytopenia: Current Insight with a Focus on Thrombopoiesis.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1678732
Laboratory Diagnostics in Thrombophilia.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1677840
Microvascular Thrombosis and Ischaemic Limb Losses in Critically Ill Patients.
来源期刊:HamostaseologieDOI:10.1055/s-0038-1676823
Impact of Telemedicine Tools on Record Keeping and Compliance in Haemophilia Care.
来源期刊:HamostaseologieDOI:10.1055/s-0038-1676128
The Role of Low Molecular Weight Heparins for Venous Thromboembolism Prevention in Medical Patients-What Is New in 2019?
来源期刊:HamostaseologieDOI:10.1055/s-0038-1677522
Causes and Secondary Prevention of Acute Ischemic Stroke in Adults.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1700502
Epidemiology and Clinical Manifestations of Immune Thrombocytopenia.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1683416
Low-Molecular-Weight Heparin in Cancer Patients: Overview and Indications.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1677796
Potential of Multidimensional, Large-scale Biodatabases to Elucidate Coagulation and Platelet Pathways as an Approach towards Precision Medicine in Thrombotic Disease.
来源期刊:HamostaseologieDOI:10.1055/s-0038-1677520
Coagulation Signalling and Metabolic Disorders: Lessons Learned from Animal Models.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1688800
How Do We Treat Pregnancy-Related Venous Thromboembolism?
来源期刊:HamostaseologieDOI:10.1055/s-0039-1700501
MYH9-Related Thrombocytopenia: Four Novel Variants Affecting the Tail Domain of the Non-Muscle Myosin Heavy Chain IIA Associated with a Mild Clinical Evolution of the Disorder.
来源期刊:HamostaseologieDOI:10.1055/s-0038-1645840
First-Line Therapy for Immune Thrombocytopenia.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1684031
Birth Control Pills and Thrombotic Risks: Differences of Contraception Methods with and without Estrogen.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1677806
Prevalence of Obesity in Young Patients with Severe Haemophilia and Its Potential Impact on Factor VIII Consumption in Germany.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1677874
Diagnosing Immune Thrombocytopenia.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1678739
Trauma-Induced Coagulopathy.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1677853
Smart Medication ™, an Electronic Diary for Surveillance of Haemophilia Home Care and Optimization of Resource Distribution.
来源期刊:HamostaseologieDOI:10.1055/s-0038-1675575
Antibodies in the Treatment of Haemophilia A-A Biochemical Perspective.
来源期刊:HamostaseologieDOI:10.1055/s-0038-1677521
Fulminant Essential Thrombocythemia Associated with Acquired Von Willebrand Syndrome and Bleeding Episodes in a 14-year-old Girl.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1679929
Therapie des Antiphospholipid-Syndroms (APS) mit DOAKs
来源期刊:HamostaseologieDOI:10.1055/s-0039-1694789
[Leitlinie der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) zur Struktur- und Prozessqualität von Hämophilie-Zentren].
来源期刊:HamostaseologieDOI:10.1055/s-0039-1688450
Acquired Haemophilia A Associated with Subsequent Hepatocellular Carcinoma.
来源期刊:HamostaseologieDOI:10.1055/s-0038-1668570
Immunomodulatory Second-Line Therapies for Immune Thrombocytopenia.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1684032
Long-Term Safety and Efficacy Data of a Plasma-Derived Factor VIII Concentrate with von Willebrand Factor for Treatment of Patients with Hemophilia A Covering 18 Years.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1698810
Child Abuse or Bleeding Disorder-An Interdisciplinary Approach.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1677714
Current Trend of Invasive Orthopaedic Interventions for People with Haemophilia in Romania: Single Centre Experience.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1677884
Thrombopoietin Receptor Agonist Use for Immune Thrombocytopaenia.
来源期刊:HamostaseologieDOI:10.1055/s-0038-1676129
Translational Research in Thrombosis and Haemostasis.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1691751
Replacement Therapy in Patients with Von Willebrand Disease-Indications and Monitoring.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1692688
Development of Haemophilia Treatment in the Eastern Part of Germany over the Last Decade in the Kompetenznetz Hämorrhagische Diathese Ost (KHDO).
来源期刊:HamostaseologieDOI:10.1055/s-0039-3399493
IWR-1 Inhibits Collagen-Induced Platelet Activation and Protects against Thrombogenesis.
来源期刊:HamostaseologieDOI:10.1055/s-0038-1676822
A Sardinian Family with Factor XI Deficiency.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1691752
Immune Thrombocytopenia-A Disease or a Group of Disorders? Where Do We Stand in 2019?
来源期刊:HamostaseologieDOI:10.1055/s-0039-1693660
A Retrospective Analysis of Clinical and Laboratory Data of Patients with Factor VII Deficiency: A Single Centre Experience.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1693425
A Prolonged Treatment Response in Acquired Von Willebrand Syndrome.
来源期刊:HamostaseologieDOI:10.1055/s-0039-1696960

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
85.45%26.56%--

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q2区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
HEMATOLOGY
Q2

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学4区
HEMATOLOGY 血液学
4区
2023年12月升级版
医学4区
HEMATOLOGY 血液学
4区
2022年12月旧的升级版
医学3区
HEMATOLOGY 血液学
4区